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ABSTRACT
The compound, 2-chloromethylbenzimidazole, was studied as a 
possible reagent for use in structure elucidation of polypeptides. The 
two approaches taken were:
1. The development of the compound as a reagent with an 
affinity for a specific side chain, e.g., the indole 
ring of tryptophan.
2. The development of the compound as a reagent for 
sequential analysis initiated at the N-terminal amino 
acid.
At low pH, the indole ring of tryptophan is an effective 
nucleophile. Alkylation of tryptophan with the fluorescent benzimidazole 
would allow a sensitive ultraviolet probe for tryptophan-containing 
peptides. It was found thAt 2-chloromethylbenziroidazole is inert to 
nucleophilic attack at low pH. This unexpected result meant that the 
development of the compound as a reagent specific for tryptophan would 
be very difficult.
Alkylation of the alpha amine of the N-terminal amino acid 
in a polypeptide by 2-chloromethylbenzimidazole leads to the possibility
of intramolecular attack by the imidazole moiety on the peptide bond.
i,
This affords a new N-terminal residue and a tagged amino acid. Several 
dipeptides were cleaved in this manner and identified on paper chroma­
tography by comparison with previously synthesized standards.
The unusual reactivity of the 2-chloromethylbenzimidazole is 
discussed and mechanisms are proposed for the alkylation reaction and 
the hydrolysis of a peptide bond.
xi
X. INTRODUCTION
Proteins are ubiquitous components found in the cells of all 
animals and plants. These complex organic nitrogenous substances serve 
indispensable functions in cellular architecture, catalysis, metabolic 
regulation, contractile processes, and immunological defense mechanisms. 
The name protein is therefore appropriately derived from the Greek word 
"protos" meaning first.
The objective of protein chemistry is to explain the phsio- 
logical functions of these complex molecules in terms of their structure. 
The task of structure determination is formidable and presents consider­
able technical difficulties because of the great diversity and complexity 
of proteins.
Knowledge of the amino acid composition of proteins represents
the first step in the structure elucidation of these substances. The next
step is to obtain information concerning the sequence of amino acids in
the peptide chain. This presents difficulties because of the many
different combinations possible by varying the kind, amount, and position
of the amino acids. For a tripeptide containing three different amino
acids, there are six possible combinations. In a polypeptide containing
twenty different amino acids in which each occurs only once, there is the
18possibility of factorial twenty or 2 x 10 different compounds.' Each 
of these contains the identical amino acids in the same proportions.
Since a polypeptide of twenty residues is a small one, the actual problem
increases very rapidly.
Sequence analysis studies began in the early twentieth century 
with the work of Fischer and his colleagues. In 1902, Hofmeister and 
Fischer independently suggested that proteins were assembled through the 
formation of secondary amide linkages between the alpha-carboxyl and 
alpha-amino functions of the adjacent amino acids. The order in which 
these adjacent amino acids appeared in the polypeptide chain was termed 
the primary sequence. Structure elucidation may begin at either the 
N-terminal or the C-terminal residue, however, N-terminal methods are by 
far the most prevalent. N-terminal methods are of interest to this 
particular study.
The initial approach to primary structure elucidation was to 
simply identify the N-terminal residue. This could be accomplished by 
a reaction in which an acylating agent combines with the N-terminal group 
through a linkage which is more stable to subsequent hydrolysis of the 
peptide chain than are the other linkages in the chain. Of course, the 
derivative so formed must be separable and capable of identification.
The very first of such procedures was that reported in I9O7 
by Fischer and Abderhalden^ who coupled beta-naphthalenesulfonylchloride 
(i) with a peptide which they suspected of being glycylalanine (II).
Upon hydrolysis, beta-naphthalenesulfonylglycine (III) was obtained, 
proving that glycine was the N-terminal (Figure 1, page 3)•
p
In 1910, Abderhalden and Blumberg developed a new N-terminal 
reagent, l-chloro-2,lt-dinitrobenzene (IV). This compound couples with 
amino acids in a sodium bicarbonate medium to give the dinitrophenyl 
amino acid (V) (see Figure 2, page It). This method was unsuccessful
+ H2NCH2C0NHCH(CH3)C02H
IX
S02NHCH2C0NHCH(CH3)C 02H
s o 2n h c h 2 c o 2 h
+ H2NCH(CH3)C02 H
FIGURE 1
Cl
r j  + h 2n c h r c o 2 h 
n o 2
IV
FIGURE 2
NHCHRCO2 H
V
N 02
5until it was revived with a slight modification by Sanger (see discussion 
on page 9 of this text).
A similar reaction involving nitro groups on a benzene ring was 
developed in I9I8 by Barger and Tutin''*. They condensed trinitrotoluene 
(VI) with carnosine (VII) and, upon hydrolysis, found dinitrotolyl-beta- 
alanine (VIII) (see Figure 3, page 6).
Bergmann, Miekeley, and Kann proposed a determination based 
on condensing the N-terminal residue with phenylisocyanate (IX) and then 
hydrolyzing the product to yield a highly insoluble hydantoin (X) derived 
from the residue. This method was first illustrated with glycylserine. 
(see Figure k, page 7)*
This procedure was subsequently extended in 1930 by Abderhalden 
and Brockmann^ who demonstrated how it could be applied step-by-step to 
the determination of amino acid residues starting from the N-terminal. 
Hydrolysis in methanol-HC-fl at 65° released the phenylisocyano-substituted 
N-terminal (XI) from the peptide chain (XII) without appreciably affecting 
the remaining peptide bonds (see Figure 5> page 8).
The first successful end-group analysis of a protein was accom- 
plished by Jensen and Evans in 1935 when they condensed insulin in a
0.066 M disodium phosphate solution with phenylisocyanate; on hydrolysis 
of the condensation product in 5 N HC-& for fifteen hours in a boiling 
water bath, the phenylhydantoin of phenylalanine was isolated.
These studies and other similar investigations led to the dis­
covery of several important and frequently interrelated aspects of N- 
terminal residue analysis. First, not all proteins have free N-terminal 
residues; some are acetylated making them inaccessable to the reagents,
n o 2
VI
NH2 (CH2 )2C0NHCH(CH2R)C02H
VII
n o 2
NH(CH2 )2C0NHCH(CH2R)C02 H
o2n
c h 3
n o 2
f^ sYNH(CH2)2C02H
0 2N - ^ j ^
c h 3
+ H2NCH(CH2R )C 02H
VIII
FIGURE 5
+ H2NCH2C0NHCH(CH20H)C02H
IX
NHC0NHCH2C0NHCH(CH20 H )C 0 2H
= 0
+ H2NCH(CH20 H )C 0 2H
X
FIGURE k
+ H2NCH(CH3)C0NHCH2C0NHCH2C02H
XII
NHC0NHCH(CH3)C0NHCH2C0NHCH2C02H
0NT * H2NCH2CONHCH2C02H
NH 
CH3
FIGURE 5
and others are cyclic in structure and therefore do not possess a free 
N-terminal amino group. Second, the protein surface contains many kinds 
of reactive residues other than alpha-amino groups which may combine 
with a variety of reagents. Third, many of these groups are not avail­
able to all reagents when proteins are in what is called the native state.
These complications make it easy to understand why the first
complete primary structure determination was not completed until 1955*
7
This accomplishment was carried out by Sanger and his associates' at 
Cambridge; as a result of this work, Sanger was awarded the Nobel Prize 
in Chemistry in 1958* They determined the primary sequence of the poly­
peptide insulin by utilizing three methods: end-group tagging with 2,4-
DNFB; partial acid hydrolysis; and, enzymatic hydrolysis.
Sanger found that l-fluoro-2,4-dinitrobenzene (XIII) reacts 
with a terminal amino group to give a yellow dinitrophenyl derivative 
(XIV). The reaction of DNFB with a protein was carried out in a mildly 
alkaline solution. The excess reagent was then removed and the protein 
then hydrolyzed with 6N HC-&. The DNP-amino acid (XV), at that time, was 
extracted into a nonpolar solvent and chromatographed (see Figure 6, page 
10).
Bovine insulin contains fifty-one amino acid residues and gives 
one amino terminal glycine and one amino terminal phenylalanine. This 
indicates that insulin is composed of two peptide chains. These chains 
are held together by the disulfide bonds of cystine. Oxidation of in­
sulin with performic acid cleaved the disulfide to two cysteic acid resi­
dues. This procedure produced two peptides which could be separated 
chromatographically. One was a basic peptide (B chain) with amino terminal
F'A + NH2CHRC0NHCHR'C02H
n o 2
XIII
n h c h r c o n h c h r 'c o 2h
0 2N
V XIV
n o 2
n h c h r c o 2h
o2n
V
n o 2
XV
+ NH2CHR'C02H
FIGURE 6
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phenylalanine and contained thirty residues. The other chain was acidic 
(A chain) with amino terminal glycine and contained twenty-one residues.
From partial acid hydrolysates of the DNP derivatives of the 
A peptide, Sanger isolated DNP glycine, DNP glycylisoleucine, DNP gly- 
cylisoleucylvaline, and DNP glycylisoleucylvalylglutamic acid. There­
fore, the A chain must have the initial sequence glycylisoleucylvalyl- 
glutamyl.... The same method was used to determine that phenylalanyl- 
valylaspartylglutamyl.... was the initial sequence of the B chain.
With each chain, partial hydrolysates were prepared by both 
acidic and enzymic hydrolysis. The small peptides were chromatographed 
and sequenced by the DNP method. Overlapping sequences were then fitted 
together. The following nonapeptide was determined in this fashion 
(Figure 7, page 11):
ser-leu- -glu-leu- -asp-tyr-
-leu-tyr- -leu-glu- -tyr-cySO^H 
-tyr-glu- -glu-asp- 
ser-leu-tyr- -leu-glu-asp- 
-leu-tyr-glu- -glu-asp-tyr-
-glu-leu-glu- 
ser-leu-tyr-glu- -glu-asp-tyr-cySO^H
Sequence: ser- leu-tyr-glu- leu-glu-asp- tyr-rcySO^H
FIGURE 7
These studies led to the linear sequence of each oxidized chain.
12
The work done by Sanger was complicated by the Inherent diffi­
culties of the methods employed. In using DNFB, the N-terminal residue 
is tagged but the remaining primary structure of the peptide is sacri­
ficed in the hydrolysis step. This loss of primary structure requires 
the use of overlapping sequences. Partial acid hydrolysis can seldom 
be employed with larger peptides or proteins since hydrolysis is essen­
tially random. And finally, proteolytic enzymes usually have primary 
and secondary sites of preferred action, leading to non-specific results. 
These difficulties have been markedly simplified by the introduction of 
reagents capable of specific internal hydrolysis of peptides and by use 
of the Edman reagent for end-group analysis.
An extensive survey of selective cleavage of peptides was
Q
presented by Witkop . One of the most useful reagents is cyanogen 
bromide which cleaves specifically at methionine residues. This reagent 
was first applied to ribonuclease by Gross and Witkop^ in 1961. There 
are four methionine residues present in ribonuclease and the cyanogen 
bromide was found to cleave at all four. The mechanism of cleavage 
can be illustrated by cleavage adjacent to methionine residue 79- The 
tripeptide sequence of ribonuclease at residues 78, 79) anc* ®0 is 
threonine-methionine-serine (XVI). Reaction of this methionyl peptide 
with cyanogen bromide (XVII) leads to formation of the cyanosulfonium 
bromide (XVIII). Displacement of methyl thiocyanate (XX) is accompanied 
by formation of the iminolactone (XIX). Hydrolysis frees the new N- 
terminal serine (XXII) and the new C-terminal homoserine lactone (XXI) 
(see Figure 8, page 13).
-HN-CH-CONHCH-CONHCH-
CHOH
CH3
c h 2
c h 2
I
s
c h 3
XVI
RCONHCH- C-NHR1
• , w
CH2 fo  
? H2
B r @  ©,
c h 3' c n
CH20H
+ CNBr
XVII
©
RCONHGH— C=NHR 
1 1
ch2 0  
xc h 2
XIX
+ CH3SCN
XVIII
XX
-HN-CH-CONHCH— G = 0  
CHOH GH2 6  
CH3 " CH*
XXI
+ h2 n c h c o n h -  
ch 2oh
XXII
FIGURE 8
Ik
Serine residues may be cleaved by an N " 0 acyl shift, fflahrney 
and Gold^ found that phenylmethanesulfonyl fluoride (XXIll) reacts selec­
tively with alpha-chymotrypsin in a 1:1 molar ratio to produce an inactive 
sulfonated enzyme. The solvolyzed IMS-chymotrypsin revealed serine as a 
new N-terminal. This supports the hypothesis that the asp(194)-ser(195) 
rearranges to an O-aspartylserine linkage (XXIV) probably formed via 
an intermediate oxazoline (XXV). At this point, the acyl rearrangement 
may be reversed (O N) or (XXIV) selectively cleaved by hydroxylamine 
or dilute alkali (see Figure 9> page 15)*
The chemical cleavage of aspartyl or glutamyl peptides is based 
on total esterification of the free carboxyl groups in methanol and HC^ 
at 0°. The ester groups are then reduced with LiBH^ in THF to the cor­
responding hydroxy amino acids (XXVI). Acidification leads to cycli- 
zation to the lactone (XXVII) and release of the adjacent amino acid as 
the new N-terminal (XXVIII). This procedure was applied to ribonuclease 
by Burstein^. All but one (i.e., cysteic acid) of the expected new 
amino terminals next to aspartic and glutamic acids— namely, threonine, 
alanine, glycine, and valine— were detected by the DNP method (see
Figure 10, page 16).
12Kaneko has worked out a method whereby threonine peptides may 
be cleaved by acylation with phosgene. The dipeptide N-benzyloxycarbonyl- 
alanylthreonine methyl ester (XXIX) was reacted with phosgene to form 
an O-chlorocarbonyl derivative (XXX). Refluxing in xylene led to cycli- 
zation to an N-acyl-2-oxooxazolidine (XXXI) from which the acyl group is 
readily cleaved by mild alkali hydrolysis. The products are the N-CBZ 
alanine (XXXIII) and the oxazolidine derivative of threonine (XXXII) (see
HN-CH-CONHCH-CO 
CHZ CH2OH 
COOH
QrS02F
XXIII
RC-NHCH
O ^ C H
0)  + H F  
0=S=0
©
R-C=NH-CH-CO- 
I I 
0  CH2
XXV
,0  ®
R-C H3N-CH-CO-
\ /
0 --------- c h 2
XXIV
-HN-CHCOOH
CH2
COOH
+ H2N-CH-CONH-
c h 2o h
FIGURE 9
16
-HN-CH-CONHCHCO- -HN-CH-CONHCH-CO-
COOH 3 COOCH3
THF
— ■■■................a>
L|B H4
HNCH-CONHCH-CO-
CH2 c h 3
CH20H
XXVI
0  ®
•HNCH —C* H3N-CH-CO-
I I  +  1
ch2 0  c h 3
ch2
XXVIII
XXVII
FIGURE 10
Figure 11, page 18).
One of the most important methods in end-group analysis was 
13introduced by Edman . He proposed the use of phenylisothiocyanate, 
a reagent which has a tremendous advantage in that it can clip off 
residues from the N-terminal amino acid without a concurrent loss of 
primary structure. After condensation of the N-terminal residue with 
0-NCS (XXXIV), cleavage is accomplished by formation of the thiaza- 
linone (XXXV) which isomerizes to the phenylthiohydantoin (XXXVI). This 
derivative is then extracted and chromatographed (see Figure 12, page 19).
More modern methods utilize improvements of the Edman method 
or new reagents which also clip off residues one at a time. Recent 
research on the technique of the Edman degradation has centered on 
improving
1. The average yield at each state so that more degrada­
tions can be performed with a single peptide or protein. If it is 
assumed that a sequence determination ceases to give useful information 
when the overall yield has fallen to 30 percent, an average yield of
99 percent is necessary if 120 cycles are to be performed; 120 residues 
is the approximate size of the smallest protein.
2. The speed and convenience of the procedure, so that 
more information can be gained each day.
ll*Edman and Begg have described an instrument called a seque- 
nator for the automatic determination of amino acid sequences in peptides. 
The heart of the sequenator is a spinning cup which spreads out the pro­
tein solution as a thin film over which another film of immiscible sol­
vent can slide. The large surface of the film makes the transfer of
CBZ-NHCH-C0NHCHC02CH3 
CH3 CHOH 
CHS
XXIX
CBZ-NHCH-CONHCHCO2CH3
c h 3 ^ c h
C \ C O o '  ^CHs
XXX
CBZ-NHCHCO-N CH-CO2CH3
c h 3 A A1
0 0 CH3
XXXI
CBZ-NHCH-COOH HN—
« +  1
c h 3
0  0
XXXIII
COCI2
 -   .
A
■>
CH-CO2CH3
isCH3
XXXII
FIGURE 11
0-N C S + NH2CHRCONHCHRCO2H
XXXIV
0-NCNHCHRCONHCHR'CO2H
It
N
//0-N— &
H  s - ^ 0
R
+ H2NCHR'C00H
XXXV
R
0 — N I
) — NH 
S
XXXVI
FIGURE 12
20
materials from one phase to another very efficient. The degradation is
followed by isolating the thiazolinones and then converting them in a
separate operation to thiohydantoins which can be identified by thin-
layer chromatography.
If the peptide is attached to a solid support, the mechanics
of performing degradations become greatly simplified. Two-phase pro-
15cedures especially lend themselves to automation. Laursen has taken 
the approach of attaching peptides to an insoluble support through the 
carboxyl groups, followed by sequential degradation from the amino ter­
minal. The N-terminal is first blocked and then the carboxyl-terminal 
is activated and coupled to the resin support. Solubility of the bound 
peptide is no longer a problem and subsequent reactions can be run in 
anhydrous solvents with good results. Laursen^ has obtained yields of 
better than 95 percent per cycle for seven cycles.
Sarantakis^ has developed a new reagent as a possible alter­
native to phenylisothiocyanate. This reagent is 2-fluoropyridine N-oxide 
(XXXVII) which couples with a dipeptide in bicarbonate solution. Re- 
fluxing the adduct in 98 percent formic acid leads to cleavage to the
2-N-glycylpyridine N-oxide (XXXVIII) and free alanine in the case of
glycylalanine. This method has not, as yet, been extensively developed 
(see Figure 13, page 21).
Another reagent which has recently been described is 3*5"
17dinitro-2-fluoroaniline. Kirk and Cohen 1 developed this reagent which 
can be modified so that coupling can be separated from cyclization. The 
modified reagent, t-butyl 3,5-dinitro-2-fluorocarbanilate (XXXIX), is 
coupled with the dipeptide. The t-butyl group is cleaved in trifluoroacetic
Ol© K O f  + H2NCH2C0NHCHC00H
6 0  C H s
XXXVII
Cl£ > O n H C H 2C 0N H C H C 00H  + HF 
0 ©  CH3
+ h 2n c h c o o h
c h 3
Ol% O nHCH2C00H
00
XXXVIII
FIGURE 13
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acid and the dihydroquinoxaline derivative (XL) of the N-terminal 
amino acid splits off. Yields of this method were low, however, due 
to formation of a benzimidazalone (XLI) (see Figure 14, page 23).
The study of the structure of proteins was paralleled by the 
study of their catalytic activity in biological processes. In I926,
J. B. Sumner isolated the enzyme urease as a crystalline protein.
Shortly thereafter, Northrop and Kunitz reported the isolation of 
crystalline pepsin, trypsin, and chymotrypsin. With the availability 
of crystalline enzymes, their properties were investigated from the 
viewpoint of protein chemistry.
The most intensively studied proteolytic enzyme has been 
chymotrypsin which is commonly obtained in crystalline form from beef 
or pork pancreas extracts.
18
In 19^9* it was discovered by Jansen and Balls that di­
isopropyl fluorophosphate inhibited chymotrypsin. Hydrolysis of the 
phosphoryl enzyme yielded O-phosphoryl serine. Chymotrypsin contains 
twenty-eight serine residues but only one reacts with the fluorophos­
phate. The extent of reaction parallels loss of activity. The forma­
tion of inactive protein by such a specific combination with an inhibi­
tor indicates that only a small well-defined part of chymotrypsin is 
responsible for its activity and that the reactive serine probably forms 
a part of the "active site" of the enzyme.
Extensive direct and indirect evidence also implicates a 
histidine residue in the catalytic activity of chymotrypsin. The effect 
of pH on the value of the kinetic constant suggests the participation of 
a grouping with a pK value similar to that of the imidazole of histidine.
25
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+ h2n c h rc o n h c h r 'c o o h
n o 2
XXXIX
HNCHRCONHCHR'COOH 
NHC02But 0
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n o 2
0 2n
n N-CHRCONHCHR’COOH 
" N ^ O
H XLI
FIGURE lA
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One of the most convincing arguments for the presence of a
histidine at or near the active site of chymotrypsin stems from the work
19of Schoeliman and Shaw . They reacted the chloromethyl ketones derived 
from N-tosyl-L-phenylalanine with chymotrypsin. This reagent reacted 
with chymotrypsin at pH 6.0 in a bimolecular reaction to produce an 
enzymatically inactive protein. A 1:1 combination of the reagent with 
the enzyme was shown to take place by employing radioactive labeling. 
Amino acid analysis of the alkylated chymotrypsin showed one histidine 
missing.
The implication of a histidine residue at the active site of
chymotrypsin led to an investigation of the ability of imidazole to
catalyze ester hydrolysis.
Model studies on the hydrolysis of esters by imidazole were
20
carried out independently by Bruice and Schmir and by Bender and 
21Turnquist . From these and subsequent investigations by Bruice and 
Jencks and their coworkers, much of the mechanistic detail of the catal­
ysis and the dependence of the rate on structural factors is known.
Since the weakly basic imidazole group is not capable of 
directly displacing the much more basic alkoxide ions from normal esters, 
most studies have dealt with the catalysis of the hydrolysis of acti­
vated esters. The hydrolysis of para-nitrophenyl acetate in the presence 
of imidazole is via pseudo first-order kinetics and may be monitored by 
following either liberation of para-phenoxide ions or protons. In this 
reaction, para-nitrophenyl acetate (XLII) is attacked by the tertiary 
nitrogen of the imidazole ring (XLIII). The products are para-nitro- 
phenoxide ion (XLIV) and N-acetylimidazole (XLV). The N-acetylimidazole
is rapidly hydrolyzed by water regenerating the imidazole (see Figure 
15> page 26). Since imidazole, at concentrations much less than that 
of the ester, brings about complete hydrolysis of the ester, it must act 
as a true catalyst turning over many times in the course of the reaction.
The effect of structural modification of imidazole on its
22catalytic ability has been studied by Bruice and Schmir . The imidazole
structure may be modified by substitution in the N-, 2-, or 4-position
as well as by fusion at the 4,5-position to an aromatic or aliphatic 
ring system. Substitution in the 4(5)-position causes very little 
steric hindrance to the catalytic activity of the imidazole. The prin­
ciple effect of this type of substitution is on the basicity of the 
imidazole nitrogen. The following table shows several imidazoles, 
their pKa values, and the apparent second-order rate constants deter­
mined at pH 8.0, 28.5 percent ethanol water, p. - 0.55> T = J>0°.
Catalyst pKa k^(liter mole**^minute"
imidazole 6.95 20.2 ± • 7
4-methylimidazole 7.45 25.1 ± .23
4-nitroimidazole 1.5 55-5 • 5
histidine methyl ester 5.2 5.6 ± •3
benzimidazole 5.4 O.96 ± .03
2-methylbenzimidazole 0.0375 .0025
These figures show that a simple correlation cannot bo drawn 
between basicity of the imidazole and catalytic ability. Thus, 4-nltro- 
imidazole is a better catalyst than imidazole at pH 8.0 where both com­
pounds are essentially in the free base form. Imidazoles with pK's of
0o - c c h 3
\
Ki— .ON
I
H
XLIII
n o 2
XLIV
+ CH3COOH
I
C
h 3c
FIGURE 15
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4.0 or lower owe their catalytic ability partially or primarily to the 
presence of their Ionic species.
The case for 2-methylbenzlmldazole is even more complex.
22
Bruice found that substitution of imidazole in the 2-position is
accompanied by a large steric effect not encountered by substitution
at the 4(5)-position. Similar steric inhibitions have been deduced
from the inability of 2-substituted imidazoles to complex with metal 
23
porphyrins. ^ This helps to explain the very poor catalytic ability of 
2-methylbenzimidazole.
Just as the rate of nucleophilic attack at the carbonyl carbon 
is a function of the basicity of the imidazole, the rate is also a 
function of the base strength of the leaving group. Assuming the for­
mation of a tetrahedral intermediate (XLVI), it can be seen that will 
increase with an increase in the pKa of the imidazole but decrease with 
an increase of the pKa of the conjugate acid of the leaving group (XLVII). 
Also, k^ will decrease with an increase in the pKa of the leaving group 
(see Figure 16, page 28).
20
Another possible mechanism suggested by Bruice and Schmir 
for the catalytic activity of imidazoles is that of general-base cata­
lysis involving partial proton transfer from a solvent molecule (see 
Figure 17, page 29). This mechanism is kinetically indistinguishable 
from the nucleophilic pathway. However, the nucleophilic attack mech­
anism can be established by spectrophotometric observation of the appear­
ance and disappearance of N-acetylimidazole (A. max 254 mix). The general-
base catalyzed pathway has been shown to be important only in the case of
24leaving groups which represent strong bases, such as alkoxides.
FIGURE 16
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The first examples of intramolecular catalysis of ester
hydrolysis by an imidazolyl group involved the esters of 2-(^/-imida-
25 26
zolyl)-phenol (XLVIIl). The rate constants for this reaction
were low and this was attributed to the possibility of a bond defor­
mation in the tricyclic transition state (see Figure 18, page 31).
27 /
Bruice and Sturtevant 1 used the ester of V “(^ -imidazolyl)-
butyric acid (XLIX) as a model for the estimation of the possible
efficiency of the imidazolyl group as a catalyst in the enzymic process.
Unlike the bimolecular reaction of imidazole with phenyl acetates or
the less efficient intramolecular catalysis involving the esters of
2-(l|./-iinidazolyl)-phenol, very rapid rates were realized (see Figure 19,
page 32).
Another example which demonstrated the higher efficiency of 
intramolecular imidazolyl catalysis was a group of esters derived from 
4-(2/-hydroxyethyl)-imidazole (L).^ A kinetic study indicated partici­
pation by imidazole in the displacement of the basic alkoxide groups.
This ability was attributed to differences of preferred ground state 
conformations of these esters in solution (see Figure 20, page 33)*
The effect of ring size on rates of intramolecular catalysis
of alkyl ester hydrolysis by the imidazole group was studied through
28hydrolysis of the acetyl ester of ^-hydroxymethylimidazole (Li). This 
ester was found to hydrolyze without imidazole participation. The re­
activity of this compound with hydroxide-ion exceeds that for the hydr­
oxide ion catalyzed hydrolysis of the highly reactive para-nitrophenyl 
acetate by a factor of ten. It also proceeds via abnormal alkyl-oxygen 
scission. The favored mechanism involves an elimination reaction forming,
XL VIII
FIGURE 18
fast
+ RCOOH
HXR
FIGURE
GOOH
FIGURE 20
RCOOH
as a transient intermediate, a diazofulvene (LII). Addition of water 
affords the 4-hydroxymethy1imidazole (see Figure 21, page 55)*
Through these studies and others, two different basic mech­
anisms of action emerge revolving around the involvement of the imidazole
29-36
group in the action of chymotrypsin. ^ ^  These two mechanisms are 
directly related to the catalytic ability of imidazole in model systems 
in that one proposed a nucleophilic attack by imidazole and the other 
proposes a general-base catalysis by imidazole.
CH2-0-C-CH3
U0
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CH2OH
N
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II. EXPERIMENTAL
The chemicals used in all the experiments described herein were 
reagent grade and, unless otherwise indicated, no further purification 
was considered necessary.
A Fisher-Johns Melting Point Apparatus was used for all melting 
points which are reported uncorrected.
The ultraviolet spectra were run on a Beckman Model DB Double 
Beam Spectrophotometer. The solvent used was 95 percent ethanol. Infra­
red spectra were run on a Beckman IR-10 Double Beam Spectrophotometer.
The 60 MHz NMR spectra were run on a Varian Model A60A NMR Spectropho­
tometer. The NMR samples were dissolved in trifluoroacetic acid and 
deuterated water. All chemical shifts are reported in parts per million 
(ppm) downfield from tetramethylsilane internal standard. The mass 
spectrograms were run on a Varian M-66 Double Focussing Mass Spectrometer 
by Mrs. Cheryl White, Scientific Research Specialist, Department of 
Chemistry, Louisiana State University, Baton Rouge.
All carbon-hydrogen-nitrogen analyses were performed by 
Mr. Ralph Seab, Scientific Research Specialist, Department of Chemistry, 
Louisiana State University, Baton Rouge.
A. Preparation of 2-Chloromethylbenzimidazole (LIIl)
37This compound was first prepared by Phillips-' .
Orthophenylenediamine (10.8 g, 0.1 moles) and chloroacetic 
acid (llf.2 g, 0.15 moles) were mixed together with 100 cc of ifN HC-& in a
37
300 ml round bottom flask. The mixture was reluxed for forty-five 
minutes and then allowed to stand overnight at room temperature.
The next day the solution was filtered and diluted with 200 cc 
of distilled water. This solution was cooled to 15°C. in an ice bath. 
Then, with vigorous stirring, the solution was neutralized with 6N 
ammonium hydroxide.
The resulting grey precipitate was filtered on a Buchner 
funnel and washed with two liters of ice cold distilled water. The 
precipitate was then left on the funnel until almost dry. Drying was 
completed by placing the crystals in a vacuum dessicator overnight.
Yield: 85 percent of grey crystals; m.p., 165° when heated
slowly.
Spectra: NMR-1; IR-1.
B. Preparation of Dibenzamido-fl^-a, 1 2  '-d)-Piperazine (LVI)
38This compound was first prepared by Day et al. . 
2-Chloromethylbenzimidazole (2 g, 0.012 moles) was added to 
100 cc of dry ethanol containing 0.3 g (0.013 moles) of sodium metal.
The mixture was refluxed for one hour and the resulting sodium chloride 
removed by filtration. The solution was stripped off on a rotary 
evaporator and the crude piperazine thus obtained was recrystallized 
from hot glacial acetic acid by the careful addition of water.
Yield: 70 percent of crystals; m.p., above 300°.
Spectra: NMR-2; Mass Spec-1.
C. Preparation of 2-Hydroxymethylbenzimidazole (LV)
38
This compound was first prepared by Day et al. . 
2-Chloromethylbenzimidazole (2 g, 0.012 moles) was refluxed in 
77 cc distilled water for forty-five minutes until solution was complete. 
The solution was cooled and neutralized with 3 percent sodium bicarbonate. 
The product was recrystallized from water.
Yield: 90 percent of crystals; m.p., 170°.
Spectra: NMR-3.
D. Preparation of Ethyl Glycine
This preparation was taken from reference 39*
Glycine (10 g, 0.133 moles) was suspended in I5O cc of absolute 
ethanol. A stream of dry hydrogen chloride gas (generated by dripping 
concentrated sulfuric acid on NaCA) was passed rapidly through the 
suspension until solution was complete. The hot reaction mixture was 
then cooled and introduction of the gas continued until saturation. The 
reaction mixture (protected from atmospheric moisture with a calcium 
chloride drying tube) was then permitted to stand at room temperature for 
three to four hours. The white needles were then filtered, washed with 
cold ethanol and cold ether, and dried In vacuo♦
Yield: 85 percent of crystals; m.p., 145-1^ 8°.
Spectra: NMR-4.
E. Preparation of 2-N-(Glycyl Ethyl Ester)-Methylbenzimidazole
The following reaction was run in a closed system which had 
been flushed out with nitrogen:
39
2-Chloromethylbenzimidazole (2 g, 0.012 moles) was added to a 
500 ml round bottom flask. Then an equimolar amount of the amino acid 
ethyl ester hydrochloride was added in 100 cc absolute ethanol. Sodium 
metal (0.55 S> 0.024 moles) was dissolved in 100 cc absolute ethanol 
and dripped into the benzimidazole solution. The solution was then 
stirred overnight after which it was neutralized with IN HCj£. The 
reaction was run on leucine ethyl ester.
Yield: 43 percent of crystals; m.p., 159°•
Spectra: NMR-6.
The reaction was also run on glycine ethyl ester.
Yield: 51 percent of crystals; m.p., 145°.
Spectra: NMR-5; IR-2.
The crude product was then dissolved in 5 of ethanol plus 
15 cc of IN HCA. A 50 cm by 5 cm column of Dowex 5OW-8X was prepared 
in its acid form and the crude product added to it.
The column was then eluted with IN HCJ& to displace the sodium 
chloride. The column was then washed with distilled water until neutral. 
Displacement was carried out with 2M ammonium hydroxide. The fractions 
were collected, dried, and identified. For the leucine ethyl ester, the
product was 2-N-leucylmethylbenzimidazole. For the glycine ethyl ester,
the product was 2-N-glycylmethylbenzimidazole. Identification was
carried out by comparison with standards on paper chromatography.
\
Analysis:
Glycine Adduct— -Calculated: C, 58*4; N, 20.50; H, 5*37* 
Found: C, 57.91; N, I9.89; H, 5-44.
ko
Leucine Adduct— Calculated: C, 60.50; N, 15*1/ H, 7*50.
Found: C, 60.1»6; N, 15.66; H, 7.20.
F. Preparation of 2-Bthoxymethylbenzimidazole (LX)
7Q
This compound was first prepared by Day et al. .
This compound was encountered as a side product in the following
reaction:
Alanylglycine (0.1 g, 0.00075 moles) and 2-chloromethylbenzi- 
midazole (0.25 g> 0.0015 moles) were mixed together in 50 cc absolute 
ethanol. The mixture was stirred while dripping sodium metal (O.O32 g,
O.OOllj- moles) dissolved in 50 cc absolute ethanol. After refluxing for
ten hours, the precipitate was filtered off and proved to be sodium
chloride and unreacted alanylglycine. The solution was stripped off and 
extracted with ether. The resulting crystals melted at l^k°. The 
structure was confirmed by NMR-7 and Mass Spec-2.
G. Attempted Synthesis of 2-N-(Glycyl Amide)-Methylbenzimidazole
Glycine amide hydrochloride (5 gj 0.0l»6 moles) was neutralized
with sodium ethoxide (0.105 g, 0.0l|6 moles) dissolved in 200 cc absolute
ethanol. 2-Chloromethylbenzimidazole (7*55 g* 0.0l*6 moles) was added 
and the solution refluxed for six hours. The precipitate which formed 
during the reflux was filtered out and proved to be sodium chloride and 
2-N-glycylmethylbenzimidazole. This was confirmed by comparison with a 
standard on paper chromatography. No 2-N-(glycyl amide)-methylbenzimi- 
dazole could be detected.
In
H. Attempted Alkylation of Glycine in Ethanol and Water
Glycine (O.5 g, O.OO67 moles) and NaOH (0.8 g, 0.02 moles) 
were dissolved in I50 cc distilled water. 2-Chloromethylbenzimldazole 
(2.2 g, O.OI3 moles) was dissolved in 50 cc ethanol and added to the 
glycine solution. The resulting homogeneous mixture was heated to 
boiling on a hot plate and heating was continued for ten minutes. The 
solution was stripped off and chromatographed. Results: A formation
of 2-hydroxymethylbenzimidazole but very little formation of the desired 
adduct.
I. Chromatography of the Amino Acids
Standard solutions of the amino acids were made in a concen­
tration of ten micromoles per ml. These solutions were spotted on 
Whatman No.l paper and run by descending chromatography in 77 percent 
ethanol. The resulting Rf values are listed in Table III, page W-.
J. Alkylation of Amino Acids in Chloroform and Water
Ten cc of IN sodium hydroxide containing glycine (0.5 g,
O.OO67 moles) was added to a 200 cc three-neck flask fitted with a 
reflux condenser and a pressure equalized dropping funnel. The dropping 
funnel contained chloroform (100 cc) in which 2-chloromethylbenzimidazole 
(1.0 g, 0.006 moles) had been dissolved.
The amino acid solution was heated to a gentle reflux at which 
time the chloroform solution was dripped in slowly over a one hour period.
1*2
After refluxing for six hours, the chloroform layer was 
removed in a separatory funnel. The chloroform was then extracted with 
dilute sodium hydroxide solution. The water layers were combined and 
stripped off. The 2-N-glycylmethylbenzimidazole was recrystallized 
from 95 percent ethanol.
The resulting product was chromatographed on Whatman No.l 
paper and the band corresponding to the desired product was removed.
This band of paper was then extracted overnight in a Soxhlet extractor 
with 93 percent ethanol. Spectra and analyses were taken on the 
resulting product of this reaction and the same reaction run on the 
other amino acids.
The analyses and melting point data for the amino acid-benzi- 
midazole adducts are presented in Table IV, page 45; the UV absorption is 
presented in Table II, page 43; and the Rf values are presented in Table 
III, page 44.
Spectra: IR-3 through IR-18; NMR-8 through NMR-17; Mass Spec-4
through Mass Spec-6.
K. Cleavage of a Dipeptide
The same conditions as stated in reaction J were used for 
several dipeptides. These conditions also promoted cleavage and the 
free amino acid released was chromatographed and quantitated. The 
dipeptides cleaved are presented in Table V, page hS.
^3
Table II
OV Absorption of the Amino Acid-Benzimidazole Adducts
Amino Acid-Benzimidazole ^ ^
Adduct max, max„
 1 _____________ 2
2-CMB 276 281 10,500
Gly 275 280 10,500
Tyr 274 282 10,500
Thr 27U 281 10,500
Pro 273 280 10,500
Met 273 279 10,500
His 272 279 10,500
0Ala 27^ 281 10,500
Tryp 276 283 10,500
Ala 274 281 10,500
Val 273 280 10,500
Ser 274 282 10,500
lieu 273 280 10,500
Leu 273 281 10,500
Glu 273 280 10,500
Arg 274 281 10,500
Glun 276 279 10,500
Lys 27^ 281 10,500
Aspn 276 283 10,500
CysSH 274 280 10,500
Cys 276 283 10,500
Asp 274 282 10,500
Table III
i
Rf Values of the Amino Acids and the Amino Acid-Benzimidazole Adducts
Amino Acid RfAmino Acids
Rf
Amino Acid-Benzimidazole 
Adducts
Other Spots
Asp .198 fo Vj3
Glu .297 •379
Aspn .180 .1*50
Pro .207 .1*62
His .237 .1*81 .l*25b .590y
Ser .29k .501*
Arg .156 .518
Gly •372 .565
Met •35^ .581 .508b .67%
Thr •379 .592
Ala .too .600
Val .1*23 .622
Tyr .1*26 .650
Lys .160 .683 . 520y .57l*b
lieu .591 .730
0Ala
COCVILf\• • 7^7
Leu .683 • 772
Tryp .JO!* Multiple
Cysh .652 Streak
These amino acid solutions were spotted on Whatman No.l paper 
and run by descending chromatography In 77 percent ethanol.
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Table IV
Analyses and Melting Point Data for the Amino Acid-Benzimidazole
Adducts
Amino Acid-Benzimidazole 
Adduct C N H
Melting
Point
Pro Calc. 59-30 16.00 5.30 211 dec.
Found 59-43 16.02 5.14
Asp Calc. 48.20 14.05 4.68 215 dec.
Found 47.92 14.10 4.35
Ser Calc. 56.30 17.92 5-53 201 dec.
Found 56.63 17.70 5.20
Gly Calc. 58.40 20.50 5-37 211 dec.
Found 57-91 19.89 5.44
Ala Calc. 51.70 16.50 5.48 I9O dec.
Found 51.62 16.47 5.40
Glu Calc. 57.20 15.17 5.43 220 dec.
Found 57.62 15.23 5.46
Leu Calc. 60.30 15.10 7.50 225 dec.
Found 60.48 15.56 7.20
0Ala Calc. 58.41 12.03 5.44 197 dec.
Found 57-99 12.06 5.08
Aspn Calc. 51.59 14.90 5.25 218 dec.
Found 51.78 14.73 5.16
Lys Calc. 49.82 15.40 6.70 182 dec.
■ Found 5O.O8 14.99 6.24
Tyr Calc. 62.20 12.77 6.07 216 dec.
Found 62.59 12.41 6.20
Val Calc. 63.20 17.01 6.88 197 dec.
Found 62.93 16.72 6.41
Table V
Dipeptides Cleaved by Reaction
ALANYL GLYCINE 
GLYCYLSERINE 
LEUCYLVALINE 
GLY C YLAS PARTATE 
LEUCYL0ALANINE 
GLYCYLLEUCINE 
GLYCYLAS PARAGINE
k6
2-Chloromethylbenzimidazole
GLYCINE AND ALA-BENZ 
SERINE AND GLY-BENZ 
VALINE AND LEU-BENZ 
ASPARTATE AND GLY-BENZ 
0ALANINE AND LEU-BENZ 
LEUCINE AND GLY-BENZ 
ASPARAGINE AND GLY-BENZ
Evidence for cleavage was based on comparison with standards on paper 
chromatography..
L. Quantitation of Cleavage
The quantitation of the preceding reaction was carried out by 
40Rosen's method
A cyanide-acetate buffer was prepared by dissolving sodium 
cyanide (4.9 nig) in 100 ml distilled water. Glacial acetic acid (5 cc) 
diluted to 75 cc was added and the solution mixed. One ml of the sodium 
cyanide solution was diluted up to 50 cc with the acetate solution.
To a 1 cc sample containing 0.02-0.04 micromoles of an amino 
acid, 0.5 ml of the cyanide-acetate buffer and 0.5 cc of a 3 percent 
ninhydrin solution (3 g nlnhydrin in 100 cc methyl cellosolve) were added. 
The mixture was heated in a stoppered tube for fifteen minutes in a 100° 
boiling water bath. Immediately after removal from bath, 5 cc °f t*16 
isopropyl alcohol-water diluent was added. The solution was then vigo­
rously shaken and permitted to cool to room temperature.
A standard solution of the amino acid being determined was 
prepared. One cc of the standard solution containing 0.1 micromole of 
the sample was treated in the same way as the unknown sample. Color 
density was read at 370 millimicrons.
The calculation was made as follows:
•a !?’ u^ nvW— ■ x concentration of standard in micromoles 0D standard —
= micromoles amino acid in sample
Results: Alanylglycine --- 48.4 percent
Glycylserine --  5^*3 percent
Glycylaspartate --  44.7 percent
Leucylphenylalanine --  30.I percent
Leucylvaline -—  3^*9 percent
M. Recovery of a Dipeptlde from Chromatography Paper
Alanylglycine (20 mg, 1x10 ^ moles) was chromatographed 
overnight on Whatman Ho.l paper using 77 percent ethanol as a solvent.
The paper was then eluted using 1*0 percent ethanol. The ethanol was 
stripped off and the alanylglycine was recovered and reacted with 
2-chloromethylbenzimidazole. The formation of 2-N-alanylmethylbenzi- 
midazole was demonstrated by paper chromatography.
N. Reaction of Different Amounts of Alanylglycine with 2-Chloromethyl- 
benzimidazole
The described coupling reaction followed by cleavage was run 
on decreasing amounts of alanylglycine. The reaction was run with 10 mg,
5 mg, and 1 mg, respectively. Each showed cleavage when chromatographed.
0. Reaction of Tryptophan and 2-Chloromethylbenzimidazole at Various pH's
A solution of tryptophan (1*0 mg, 10-^ moles) was made in 200 cc
- *5
water. To this was added 2-chloromethylbenzimidazole (0.32 g, 10 J moles) 
dissolved in 200 cc acetone. The resulting solution was divided into 
four parts of 100 cc each. The first aliquot was adjusted to pH 3-0 with 
dilute HCfy the second was adjusted to pH 5*6 with dilute HC^ the third 
was already pH 7*0; and the fourth was adjusted to pH 8 with NaHCO^. The 
first three aliquots were stirred for 21*- hours.
Results; The first aliquot (pH 3) showed no reaction. The 
second aliquot (pH 5*6) showed no reaction. The third aliquot showed 
a small amount of 2-hydroxymethylbenzimidazole. These results were based 
on comparison with standards by paper chromatography.
The fourth aliquot reacted rapidly and the pH could be seen 
to decrease on the pH meter. As soon as the pH was initially adjusted 
to 8, the pH started to drop. Addition of base maintained the pH at 8. 
Chromotography of product revealed no unreacted 2-chloromethylbenzimi­
dazole and no unreacted tryptophan.
P. Separation of Alkylation and Cleavage of a Dipeptide
Alanylglycine (j x 10 ^M, 100 mg) and NaOH (55 mg> 1*4 x 10 ^M) 
were dissolved in 50 cc of 95 percent EtOH. The resulting solution was 
heated to boiling and 2-chloromethylbenzimidazole (250 mg, 1.4 x 10 "m) 
was added and boiling continued for thirty minutes. The solvent was 
then stripped off and the product extracted with diethyl ether. Chroma­
tography on Whatman No.l paper showed free alanylglycine and a yellowish 
spot at Rf 0.750* No 2-N-alanylmethylbenzimidazole was evident.
The product was then incubated at 37°C. for thirty minutes in 
acetic acid which had been previously saturated with dry HCA. After 
thirty minutes, the acetic acid was stripped off, water added and stripped 
off again. Chromatography of the product showed presence of glycine, 
alanylglycine, and 2-N-alanylmethylbenzimidazole, as compared to standards.
Q. Spectra
IR, NMR and Mass Spec (see following pages 50 through 78).
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III. DISCUSSION
The principal method for sequence analysis in current use is 
13the Edman method introduced in 1950* Most of the recent advances in
llj. 15
sequence analysis have been in improving this method ’ and a few have
16 1*7been based on new reagents * . While most of our knowledge of primary
sequence of polypeptides is based on the Edman method, this method has 
the disadvantage of being useful for only the first 8-10 residues of 
the polypeptide chain. After this point is reached, yields become very 
low and are no longer useful. One of the main reasons for this limita­
tion is that acid treatment is required for the release of the phenyl- 
thiohydantoin and peptide from the phenylthiocarbonyl peptide derivative 
(see Figure 12, page 19). Acid treatment causes intra-chain peptide 
hydrolysis and destruction of some of the acid labile amino acid residues 
(e.g., serine and tryptophan). This has been overcome to some extent by
the development of specific reagents for intra-chain peptide hydrolysis
9-12to give polypeptides of usable size. Therefore, it is desirable to
pursue the development of specific reagents which will function under 
milder conditions.
The study of the structure and function of proteins led to the 
discovery that a certain group of proteins could catalyze the hydrolysis 
of the peptide bond. It was also found that one of these enzymes (i.e. 
chymotrypsin) required a histidine residue for enzymatic activity.
Several studies have elucidated the mode of action of histidine catalyzed
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hydrolysis and have shown that amides and esters can be very efficiently
20 21hydrolyzed by imidazole and related compounds. * The currently useful 
methods of end-group analysis consist of tagging the N-terminal residue 
and cleaving the first peptide bond through formation of a cyclic five- 
or six-membered intermediate.^^ This requires a nucleophilic center 
6 or e to the amide bond. Using this approach to construct a model based 
on imidazole required an imidazole substituted so that the desired inter­
mediate could be formed. One such reagent is 2-chloromethylbenzimidazole 
(LIIl). This highly-reactive fluorescent compound condenses with amines 
(LIV)^* (see Figure 24, page 83); and, if the amine of choice is an N- 
terminal amino acid in a peptide chain, the nucleophilic center of the 
imidazole is e to the peptide bond (see Figure 22, page 8l). Under the 
appropriate conditions, we then have the possibility of intramolecular 
nucleophilic attack by the imidazole moiety on the amide bond of the N- 
terminal residue leading to the desired specific cleavage (see Figure 23> 
page 82). In addition, the reactivity of 2-chloromethylbenzimidazole 
reminds one of the reactivity shown by Koshland’s reagent toward tryto- 
phan; and, therefore, it may be possible to develop 2-chloromethylbenzi- 
midazole into a reagent which is selective for certain residues in the 
polypeptide chain.
As a reagent for the study of peptide structure, 2-chloromethyl­
benzimidazole has three possibilities:
1. N-terminal tagging and cleavage;
2. Specific intra-chain cleavage;
3. Specific residue affinity leading to quantitation by 
UV absorption.
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Although the chemistry of 2-chloromethylbenzimidazole has been
57studied only sparsely since its initial synthesis by Phillips , it is !
quite evident that the compound is highly-reactive toward nucleophilic
4lreagents. In the presence of amines, Bloom and Day have shown that 
2-chloromethylbenzimidazole is readily converted into corresponding alkyl- 
aminomethyl derivatives. For example, when methyl amine is reacted in a 
2:1 ratio with 2-chloromethylbenzimidazole, the product obtained in 80 
percent yield is 2-(methylaminomethyl)benzimidazole.
The nucleophilic reactivity of the reagent was further studied 
by Skolnik and Day^®. These investigators discovered that 2-chloromethyl­
benzimidazole rapidly reacts with water to afford the expected 2-hydro- 
xymethylbenzimidazole (LV) (see Figure 2k, page 83). Surprisingly, how­
ever, the reagent in the presence of alkoxide does not yield the William­
son product (IX), but instead affords a dimer (LVI) (see Figure 2k, page 
83)* In contrast to this, the substituted halobenzimidazole, 2-(of- 
chloroisopropyl)-benzimidazole (LVII) (see Figure 2k, page 83) affords 
only the hydroxy (LVIII) and alkoxy (LIX) derivatives under these con­
ditions. It was also noted by these investigators that the reagent 
reacts with both silver nitrate and potassium iodide; these results 
indicate that the benzimidazole reacts via S^l and bimolecular reaction 
pathways. These results have been verified in this laboratory, and 
although these nucleophilic reactions are not completely understood at 
this point, it is quite apparent that 2-chloromethylbenzimidazole should 
readily react with amino acids and peptides.
The development of 2-chloromethylbenzimidazole as a specific 
reagent for the study of protein structure requires that it be made to
react exclusively with one type of residue in the peptide chain. At 
low pH, the only side chains which retain nucleophilic character are 
the indole ring of tryptophan and the sulfhydryl group of cysteine. One 
would expect that, under acid conditions, the enamine present in the 
indole ring of tryptophan would react with an alkylating agent. This is
k2supported by work done by Kbshland using the reagent 2-hydroxy-5- 
nitrobenzyl bromide. At pH 3 this reagent reacted rapidly and completely 
with tryptophan. Using the conditions described by Koshland, it was 
found that 2-chloromethylbenzimidazole is stable to nucleophilic attack 
under these conditions. Raising the pH to 5.6 also resulted in starting 
materials being recovered intact. At pH J, after stirring for several 
hours, a small amount of the alcohol was formed. At pH 8, however, the 
reagent reacted so rapidly that constant addition of base was required 
to maintain the pH at 8. Chromatography of the products of this re­
action shoed that several products had been formed. After running the 
chromatogram overnight in 77 percent ethanol, it was dried and developed 
with ninhydrin. Besides the usual purple spot resulting from ninhydrin 
plus a free amino acid, a brilliant turquoise spot was noted. There 
was also a yellow spot similar to that formed in the reaction between 
ninhydrin and proline. None of these products were formed in sufficient 
quantity for analysis, however, structures may be postulated by analogy 
to products formed in Kbshland's reaction. These structures correspond 
to alkylation of the indole ring and a rearranged adduct (see Figure 25, 
page 86).
The inability of 2-chloromethylbenzimidazole to react with 
tryptophan under acidic conditions was quite unexpected, and this failure
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required a re-evaluation of the chemistry of the reagent. If one 
postulates that the main reaction pathway involves an S^l mechanism, 
then the failure of the tryptophan reaction is easily understood.
I
LXI
H
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FIGURE 26
The rate determining step of this reaction sequence is the ionization 
step forming the cation UCI; the cation then rapidly reacts with solvent 
to yield the 2-substituted methylbenzimidazole. In the pH range of 
the rate of this reaction would be expected to be markedly decreased 
because, under these conditions, the reagent would exist as the benzimi- 
dazolium ion LXII. The ionization step, under these conditions, would
X H LXii
FIGURE 27
require tie production of a second cation on the charged benzimidazole 
moiety LXI1I. The formation of this ion would, therefore, be highly
H H H
C H ®  < -- >
LXIII
FIGURE 28
unlikely because of the energy required to produce the unfavorable 
dipole interaction which exists in this intermediate LXI11. Thus, the 
inert nature of 2-chloromethylbenzimidazole under acidic conditions can 
be explained in these terms. When the pH of the tryptophan reaction was 
adjusted to 8, a very rapid reaction occurred. Under these condition, 
it is highly likely that the S^l mechanism will give way to an Eg 
mechanism:
LXIVOH
FIGURE 29
This sequence involves the elimination of chloride ion with the subse­
quent formation of a highly-reactive diazofulvene intermediate LXIV.
This intermediate would be expected to react with tryptophan to afford 
the analogues of Koshland's compounds.
The tryptophan study indicated that it would be difficult to 
develop 2-chloromethylbenzimidazole into a selective reagent for pro­
tein analysis. We, therefore, turned our attention to the reactions 
between the reagent and amino acids and peptides. The initial experi­
ment in the area involved the alkylation of glycine. The amino acid 
was dissolved in water containing two moles of sodium hydroxide; the 
reagent was then added and the reaction mixture was heated for approx­
imately thirty minutes. Chromatography of the results on Whatman No.l 
paper showed a large amount of unreacted glycine and formation of 2- 
hydroxymethylbenzimidazole. Ninhydrin, however, revealed the presence 
of a new compound with a Rf value of 0.565* It was quite obvious, 
however, from the considerable amounts of glycine and 2-hydroxymethyl- 
benzimidazole present in the reaction mixture that a more suitable 
method would have to be developed. To attain this end, a systematic 
investigation of the effects of solvents, reaction times, and alkalis 
on the reaction were investigated. All of these attempts, however, led 
to the same disappointing results encountered earlier.
On problem considered was the possibility of alkylation of the 
carboxy group of the amino acid (LXV) as well as the desired N-alkylation 
(LXVl) (see Figure JO, page 90)• This would give a mixture of products 
including the alcohol. To rule out the possibility of O-alkylation, 
glycine ethyl ester was prepared. Formation of the ester also destroyed
90
i
+ H2NCHRCOOH
H
1
H
O^CHRNHg
n
LXV
I
H
H
N CHRCOOH
LXV I
FIGURE 30
the zwitterion character of the amino acid allowing the reaction to be 
run under anhydrous conditions. These conditions would also stop 
formation of the alcohol. An NMR spectra taken of the crude benzimi- 
dazole-glycine ethyl ester adduct showed the aromatic benzimidazole 
protons at 7*4 and the benzimidazole methylene at 4.87. Also present 
was the glycine methylene at 4.2 and the ethyl group at 3.6 and 1.2. An 
attempt at purification of the benzimidazole-glycine ethyl ester adduct 
resulted in the collection of the adduct minus the ethyl group. The 
acid form of the Dowex 5OW-8X resin used in the purification promoted 
cleavage of the ester group demonstrating that, under acid conditions,, 
the imidazole moiety could clip off an ester group (see Figure 31, page 
92). The same results were obtained using leucine ethyl ester.
Using the same conditions as employed for the ester, 2-chloro- 
methylbenzimidazole was reacted with glycine amide hydrochloride. A 
precipitate formed immediately. Analysis of the precipitate showed the 
presence of NaCA and 2-N-glycylmethylbenzimidazole. Evaporation of the 
solvent did not reveal the presence of any benzimidazole-glycine amide 
adduct. The conclusions reached were that, under the basic conditions 
employed, the benzimidazole-glycine amide adduct formed but the amide 
was hydrolyzed off by the imidazole (see Figure 31, page 92)•
The use of the ester and amide allowed the unambiguous 
characterization of the glycyl- and leucyl-benzimidazole adduct. The 
purification of these compounds for analysis was extremely difficult, 
however. The zwitterion character caused the retention of different 
ions and water. Numerous recrystallizations resulted in analyses which
Cl ',0
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were off by a percent even though NMR spectra indicated the presence of 
only one compound. Reasonably pure compounds were finally obtained by 
recrystallization from aqueous HC£ containing a small amount of dioxane. 
Once the identity of this family of derivatives was established, it was 
necessary to find conditions which would allow their formation from free 
amino acids.
The technique resolved for use with free amino acids was much 
more successful. The amino acid was dissolved in a minimal amount of IN 
NaOH while the 2-chloromethylbenzimidazole was dissolved in CHC^. The 
two non-miscible solvents were then stirred together vigorously to 
achieve a good interface. This caused the formation of a pink emulsion 
which, in some cases, was difficult to disperse. However, these con­
ditions allowed a much higher amine:hydroxide ratio so that the amine 
could better compete for the benzimidazole. Glycine was tried first 
under these conditions and chromatography of the results showed free 
glycine still present, an intense orange-yellow spot at Rf 5*65* anc* a 
pale blue spot at the solvent front which was determined to be the 
benzimidazole alcohol. The orange-yellow spot had the same Rf value as 
the compound analyzed to be 2-N-glycylmethylbenzimidazole, so this spot 
was assumed to correspond to the desired product.
Since this technique was more successful, it was used to make 
derivatives of the other amino acids (see Table 111, page Ml). The 
results with the monofunctional amino acids were similar to that of 
glycine. In the case of aspartate and glutamate, a fluorescent spot 
which gave a purple color with ninhydrin was detected and this was
thought to be from alkylation of the terminal carboxyl group. All had 
spots of various shades and intensities of yellow when developed with 
ninhydrin. This was considered to be similar to the reaction of proline, 
a secondary amine, with ninhydrin. NMR's integrated to confirm that 
mono-alkylatlon had taken place and each NMR showed the aromatic benzi- 
midazole protons, the benzimidazole methylene singlet, and the charac­
teristic absorptions of each amino acid. The mass specs taken also showed 
mono-alkylation. The molecular-ion of each was the dehydration product 
of the amino acid-benzlmldazole adduct (LXVIl). Loss of the amino acid 
side chain gave a peak at m/e 186 (LXVIII) for each one except glycine, 
which was at 187* Also present in each was a strong peak at m/e 131 
which corresponds to the molecular weight of the benzimidazole (LXIX)
(see Figure 32, pegs 95)-
In the case of lysine, tyrosine, histidine, cysteine, and 
methionine, there is the possibility of alkylation on the side chain.
In each reaction concerning these amino acids, chromatography showed 
the formation of multiple products. The products in histidine were so 
close together on the chromatogram that they were almost indistln- 
quishible. Lysine and tyrosine were well enough resolved using 77 per­
cent ethanol that samples could be cut from the paper and eluted for 
characterisation. An analysis of the lysine adduct was obtained which 
showed mono-alkylation. Assignment of structure to alkylation at the « 
or s amine would be dlffuclt since both have the same analysis and both 
give a yellow color with ninhydrin. The tyrosine derivative also 
analysed as the mono-adduct. While both g-amlno and phenolic alkylation
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occurred, the derivative was chosen which gave a yellow color with 
ninhydrin. Methionine did not give enough of any one derivative in 
order for an analysis to be performed.
Once conditions had been established for the amino acid 
reaction, these same conditions were used for reacting a series of 
dipeptides. The standards synthesized from the amino acids could then 
be used for comparison in the dipeptide cleavage. When the chloroform 
method was tried on several dipeptides, we were amazed to discover that 
the peptide bond had been cleaved under these conditions. Several of the 
dipeptides cleaved were quantitated. This entailed chromatographing the 
reaction mixtures on Whatman No.l paper in 77 percent ethanol. The 
released amino acid was then eluted from the paper by reluxing it over­
night in 50 percent ethanol in a Soxhlet extractor. Quantitation with 
ninhydrin showed the cleavages had taken place in the following amounts:
Table VI
Quantitation of Cleavage of Dipeptides
Glycylserine   5^*3 percent
Alanylglycine -- 48.4 percent
Glycylaspartate -- 44.7 percent
Leucylvaline   3^*9 percent
Leucylphenylalanine - 30.I percent
The cleavage went progressively lower as the side chains increased in 
length. This might indicate a steric inhibition of the initial alky­
lation reaction. Any factor inhibiting this reaction would have adverse 
effects due to the high reactivity of the benzimidazole intermediate.
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The high reactivity of the benzimidazole raised the possibility 
of alkylation of the second residue of the peptide after the first resi­
due had been cleaved. However, in the case of alanylglycine, no evidence 
of 2-N-glycylmethylbenzimidazole could be found. One method of stopping 
the possibility of secondary alkylation is to separate the alkylation 
step from the cleavage step. It was found that this could be achieved 
for the benzimidazole reagent by carrying out the reaction in 95 percent 
ethanol and NaOH. Under these conditions, the alkylated alanylglycine 
could be isolated and subsequent cleavage carried out in glacial acetic 
acid saturated with HC-fc and heated at 37° £°r thirty minutes. Chroma­
tography of the results showed free glycine and 2-N-alanylmethylbenzi- 
midazole.
The cleavage of dipeptides by benzimidazole can follow two
mechanistically different but kinetically indistinguishable paths. The
pathway available for poor leaving groups is that of general base cata- 
20 1*3lysis. * ^ In this pathway, there is a partial proton transfer from 
solvent to imidazole, aiding solvent attack on the peptide bond (see
Figure 33, page 98).
1
The other possible mechanism is that of intramolecular nucleo- 
philic attack. This involves attack of the basic tertiary nitrogen
of the imidazole ring on the amide bond. This attack leads to the 
possibility of two types of hydrogen bonding. Hydrogen bonding to the 
oxy-anion may take place (LXX). This would probably lead to expulsion 
on the imidazole from the tetrahedral intermediate and a return to 
starting material (see Figure 3 ^  pages 99-100). When the amide
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nitrogen assumes an axial position, however (LXXl), hydrogen bonding 
can lead to proton transfer of the axial amine proton (see Figure jk, 
pages 99”100). Collapse of the tetrahedral intermediate then leads to 
expulsion of the protonated amine. The intermediate formed (LXXII) by 
this expulsion is rapidly hydrolyzed. The overall results are the 
tagging and cleavage of the N-terminal residue leaving a new N-terminal 
amino acid.
Support for the intramolecular hydrogen bonding can be found
in work done by several groups in their study of the facilitation of
1(4-47 48
ester hydrolysis by neighboring amino groups. 1 Jencks and 
4g
Wolfenden ^ have done model system studies of the hydrolysis of amino 
acyl RNA. The enhanced rate of these esters was rationalized in terms 
of intramolecular hydrogen bonding (LXXIll) (see Figure yj, page 102). 
These considerations lead us to favor the intramolecular nucleophilic 
attack pathway.
The overall cleavage seems to be very efficient since chromato­
graphy of the resulting products revealed fluorescence in only one spot, 
that of the tagged N-terminal amino acid. The main problem encountered 
was with the initial alkylation, which went in poor yields. So, although 
we were able to characterize a new group of amino acid-benzimidazole 
derivatives and catalyze the specific cleavage of peptides under mild 
conditions, we were unable to accomplish this in high yields.
There seems to be two alternatives available to overcome the
difficulties encountered. One is to alter the structure in some way
23
so as to decrease the reactivity of the molecule. Day ^ found that 
replacing the imidazole hydrogen with a methyl group decreased the
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reactivity of 2-chloromethylbenzimidazole. Alkylation of this nitrogen
18
only reduces the catalytic ability of imidazole by 25 percent.
The other alternative is to adopt a solid state procedure
which allows one to overcome solubility problems. An adaptation of
15Laursen's procedure would allow alkylation to take place in a non-
aqueous solvent. If this solvent was dioxane, for example, solvolysis 
of the benzimidazole would be very unlikely and the a-amine would be 
better able to compete. After stepwise degradation, the tagged amino 
acids could be identified by paper chromatography. Another possible 
method of identification is mass spec. It was noted that, due to the 
stability of the aromatic benzimidazole moiety, the amino acid-benzimi- 
dazole adducts gave prominent P-18 peaks in their mass spectrum. This 
would allow easy identification based on the molecular weight of each 
amino acid.
Benzimidazole has several advantages which make its further 
development attractive. It can catalyze the specific cleavage of amide 
bonds in a basic medium. The alkylation and cleavage can take place 
in one operation and determination of the amino acid-benzimidazole adduct 
is simplified due to the fluorescence of the benzimidazole moiety. All 
of these advantages indicate that a useful reagent could be developed by 
further study in this area.
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